LEXINGTON, Mass. — October 30, 2025 — Leads & Copy — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) will participate in the Stifel 2025 Healthcare Conference in New York, NY. Company management will engage in a 30-minute Q&A session with the host analyst on Tuesday, November 11, 2025, at 11:20 a.m. ET.
A live webcast will be available on the Rapid Micro Biosystems investor relations website and can be accessed here. The webcast will be archived for replay after the event.
Rapid Micro Biosystems provides automation solutions for healthcare product manufacturing. Its Growth Direct system automates microbial quality control testing, offering faster results, accuracy, efficiency, and compliance.
The company is based in Lexington, Massachusetts, with manufacturing in Lowell, Massachusetts, and global locations in Switzerland, Germany, and the Netherlands.
Investor Contact: Michael Beaulieu, CFA, Vice President, Investor Relations and Corporate Communications, mbeaulieu@rapidmicrobio.com
Media Contact: media@rapidmicrobio.com
Source: Rapid Micro Biosystems
